GI & Endoscopy

A study published in PLOS One examined gastroenterologists' motives for prescribing biosimilars, assessed treatment preferences and explored patient attitudes toward biosimilars.

A survey conducted by the Esophageal Cancer Action Network revealed that 86 percent of Americans don't know that reflux disease can cause esophageal cancer.

A study published in BMC Cancer examined how Omega-3 polyunsaturated fatty acids, n-3 PUFAs, affect nutritional status and immune function in GI cancer patients undergoing surgery.

Here are the five most read gastroenterology/endoscopy stories from April 10 to April 14, 2017.

Here are three gastroenterologists making headlines the week of April 3, 2017.

Joseph Karacic, MD, is a gastroenterologist with Chicago-based Northwestern Medicine.

The Ohio Gastroenterology & Liver Institute's Pradeep Bekal, MD, opened the HyGIeaCare Center in February, the Cincinnati Business Journal reports. Both practices are based in Cincinnati.

Allergan and Ironwood Pharmaceuticals, in partnership with the American Gastroenterological Association, launched a campaign focused on bowel health's importance.

Key Capital announced positive results for its liver cancer immunotherapy product hepcortespenlisimut-L.

The FDA granted New York City-based Bristol-Myers Squibb's biologics license application for Opdivo priority review status.